EUVIMEDEUVIMED entdecken
Crossref

In vitro cancer cell line luminescence‐based validation of anticancer phytocompounds obtained from Leucas biflora against HELA cervical and A549 lung cancer cells

Kandasamy Chitra iD, Muthusamy Sureshkumar, Aiswarya Muraleedharan iD, Ponnusamy Selvamaleeswaran, Thangaswamy Selvankumar iD, Rathinavel Thirumalaisamy iD, Nouf M Alyami, Sulaiman Ali Alharbi

Luminescence · 2024

DOI: 10.1002/bio.4855 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2024. Verfasst von Kandasamy Chitra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Muthayammal College of Arts and Science (A Unit of VANETRA Group) (Autonomous), Affiliated to Periyar University, Salem,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phytogenic, Plant Extracts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current research aims to screen the anticancer prospective of Leucas biflora phytocompounds against apoptotic regulator target protein essential for cancer progression. In gas chromatography–mass spectrometry analysis major phytocompounds such as tetracosahexaene, squalene, phytol, 22‐stigmasten‐3‐one, stigmasterol, fluorene, and 1,4‐dihydro were identified in ethanolic leaf extract of Leucas biflora . In vitro, the free radical scavenging potential of ethanolic leaf extract of Leucas biflora was examined through its DPPH and ABTS radical scavenging potential IC 50 value 15.35 and 13.20 μg/ml, respectively. Dose‐dependent cytotoxicity was monitored against both A549 lung cancer and HELA cervical cancer cells. Leucas biflora ethanolic leaf extract highly reduces the cell viability of both HELA and A549 cells in in vitro cytotoxicity assays. Leucas biflora ethanolic extract produces 23.76% and 29.76% viability rates against A549 lung and HELA cervical cancer cell lines, and their IC 50 values differ slightly at 95.80 and 90.40 μg/ml, respectively. In molecular docking analysis lung cancer target protein–ligand complex 5Y9T‐16132746 showed a maximum score of −14 kcal/mol by exhibiting stable binding affinity and interactions among all screened complexes. Based on docking score nine phytocompounds from Leucas biflora and two reference standard drugs were chosen for further analysis. Further validation reveals that the fluorene, 1,4‐dihydro possess good ADMET, Bioactivity and density functional theory indices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, PhytogenicPlant ExtractsHumansHeLa CellsA549 CellsDrug Screening Assays, AntitumorCell SurvivalLuminescenceMolecular Docking SimulationLung NeoplasmsDose-Response Relationship, DrugPlant LeavesMolecular StructureUterine Cervical Neoplasms

Stichwörter der Autor:innen

A549HELALeucas biflorain vitroluminescence

Substanzen

Antineoplastic Agents, PhytogenicPlant Extracts

Autor:innen und Institutionen

  • Department of Biotechnology, Muthayammal College of Arts and Science (A Unit of VANETRA Group) (Autonomous), Affiliated to Periyar University, Salem, Rasipuram, Tamil Nadu, India.
  • Department of Zoology, Thiruvalluvar Government Arts College, Rasipuram, Tamil Nadu, India.
  • Department of Biochemistry, KMCT Medical College, Kozhikode, Kerala, India.
  • Biomaterials Research Unit, Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
  • Department of Biotechnology, Sona College of Arts and Science, Salem, Tamil Nadu, India.
  • Department of Zoology, College of Science, King Saud University, PO Box - 2455, Riyadh-11451, Saudi Arabia.

ORCID-Profile: Kandasamy Chitra, Aiswarya Muraleedharan, Thangaswamy Selvankumar, Rathinavel Thirumalaisamy

Förderung

  • King Saud University

Zitieren

APA

Chitra, K., Sureshkumar, M., Muraleedharan, A., Selvamaleeswaran, P., Selvankumar, T., Thirumalaisamy, R., Alyami, N. M., & Alharbi, S. A. (2024). In vitro cancer cell line luminescence‐based validation of anticancer phytocompounds obtained from Leucas biflora against HELA cervical and A549 lung cancer cells. Luminescence. https://doi.org/10.1002/bio.4855

Vancouver

Chitra K, Sureshkumar M, Muraleedharan A, Selvamaleeswaran P, Selvankumar T, Thirumalaisamy R, et al. In vitro cancer cell line luminescence‐based validation of anticancer phytocompounds obtained from Leucas biflora against HELA cervical and A549 lung cancer cells. Luminescence. 2024. doi:10.1002/bio.4855

BibTeX
@article{Chitra2024,
  author = {Chitra, Kandasamy and Sureshkumar, Muthusamy and Muraleedharan, Aiswarya and Selvamaleeswaran, Ponnusamy and Selvankumar, Thangaswamy and Thirumalaisamy, Rathinavel and Alyami, Nouf M and Alharbi, Sulaiman Ali},
  title = {In vitro cancer cell line luminescence‐based validation of anticancer phytocompounds obtained from Leucas biflora against HELA cervical and A549 lung cancer cells},
  journal = {Luminescence},
  year = {2024},
  doi = {10.1002/bio.4855}
}
Kostenlos starten →